Short Interest in Ainos, Inc. (NASDAQ:AIMD) Rises By 1,959.7%

Ainos, Inc. (NASDAQ:AIMD) saw a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 364,031 shares, an increase of 1,959.7% from the January 15th total of 17,674 shares. Based on an average daily volume of 3,475,966 shares, the short-interest ratio is presently 0.1 days. Currently, 8.4% of the company’s shares are short sold. Currently, 8.4% of the company’s shares are short sold. Based on an average daily volume of 3,475,966 shares, the short-interest ratio is presently 0.1 days.

Insider Activity at Ainos

In other Ainos news, major shareholder Carbon Nano Technology Taiwan sold 46,000 shares of the business’s stock in a transaction on Wednesday, January 28th. The shares were sold at an average price of $2.17, for a total value of $99,820.00. Following the completion of the sale, the insider directly owned 989,925 shares of the company’s stock, valued at $2,148,137.25. The trade was a 4.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Over the last 90 days, insiders have sold 47,281 shares of company stock worth $102,152. 9.79% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Ainos

A hedge fund recently bought a new stake in Ainos stock. Two Sigma Investments LP acquired a new position in Ainos, Inc. (NASDAQ:AIMD) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 23,008 shares of the company’s stock, valued at approximately $80,000. Two Sigma Investments LP owned 0.48% of Ainos at the end of the most recent reporting period.

Ainos Stock Down 1.6%

Shares of NASDAQ:AIMD traded down $0.03 during midday trading on Tuesday, reaching $1.85. The company’s stock had a trading volume of 41,712 shares, compared to its average volume of 1,418,321. Ainos has a 12-month low of $1.61 and a 12-month high of $4.50. The firm has a market capitalization of $8.90 million, a P/E ratio of -0.46 and a beta of 2.49. The firm has a 50 day moving average of $1.98 and a 200-day moving average of $2.81. The company has a quick ratio of 2.67, a current ratio of 2.96 and a debt-to-equity ratio of 1.10.

Ainos (NASDAQ:AIMD) last announced its quarterly earnings data on Thursday, November 13th. The company reported ($0.64) earnings per share for the quarter. The business had revenue of $0.00 million for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Ainos in a report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of “Sell”.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.